These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 8792815)
21. FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays. Sølvsten C; Nielsen AL Gene; 2011 Oct; 486(1-2):15-22. PubMed ID: 21767618 [TBL] [Abstract][Full Text] [Related]
22. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Kenneson A; Zhang F; Hagedorn CH; Warren ST Hum Mol Genet; 2001 Jul; 10(14):1449-54. PubMed ID: 11448936 [TBL] [Abstract][Full Text] [Related]
23. Fragile X syndrome (review). Pimentel MM Int J Mol Med; 1999 Jun; 3(6):639-45. PubMed ID: 10341296 [TBL] [Abstract][Full Text] [Related]
24. Unusual mutations in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats. Wöhrle D; Salat U; Gläser D; Mücke J; Meisel-Stosiek M; Schindler D; Vogel W; Steinbach P J Med Genet; 1998 Feb; 35(2):103-11. PubMed ID: 9507388 [TBL] [Abstract][Full Text] [Related]
25. Qualitative assessment of FMR1 (CGG)n triplet repeat status in normal, intermediate, premutation, full mutation, and mosaic carriers in both sexes: implications for fragile X syndrome carrier and newborn screening. Hantash FM; Goos DG; Tsao D; Quan F; Buller-Burckle A; Peng M; Jarvis M; Sun W; Strom CM Genet Med; 2010 Mar; 12(3):162-73. PubMed ID: 20168238 [TBL] [Abstract][Full Text] [Related]
26. A neuropsychological investigation of male premutation carriers of fragile X syndrome. Moore CJ; Daly EM; Schmitz N; Tassone F; Tysoe C; Hagerman RJ; Hagerman PJ; Morris RG; Murphy KC; Murphy DG Neuropsychologia; 2004; 42(14):1934-47. PubMed ID: 15381024 [TBL] [Abstract][Full Text] [Related]
27. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. Jacquemont S; Hagerman RJ; Leehey MA; Hall DA; Levine RA; Brunberg JA; Zhang L; Jardini T; Gane LW; Harris SW; Herman K; Grigsby J; Greco CM; Berry-Kravis E; Tassone F; Hagerman PJ JAMA; 2004 Jan; 291(4):460-9. PubMed ID: 14747503 [TBL] [Abstract][Full Text] [Related]
28. An assessment of screening strategies for fragile X syndrome in the UK. Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423 [TBL] [Abstract][Full Text] [Related]
29. A family with two female siblings with compound heterozygous FMR1 premutation alleles. Basuta K; Lozano R; Schneider A; Yrigollen CM; Hessl D; Hagerman RJ; Tassone F Clin Genet; 2014 May; 85(5):458-63. PubMed ID: 23786467 [TBL] [Abstract][Full Text] [Related]
30. Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Tassone F; Hagerman RJ; Loesch DZ; Lachiewicz A; Taylor AK; Hagerman PJ Am J Med Genet; 2000 Sep; 94(3):232-6. PubMed ID: 10995510 [TBL] [Abstract][Full Text] [Related]
31. Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models. García-Alegría E; Ibáñez B; Mínguez M; Poch M; Valiente A; Sanz-Parra A; Martinez-Bouzas C; Beristain E; Tejada MI RNA; 2007 May; 13(5):756-62. PubMed ID: 17449730 [TBL] [Abstract][Full Text] [Related]
32. Contribution of the FMR1 gene mutation to human intellectual dysfunction. Reiss AL; Freund LS; Baumgardner TL; Abrams MT; Denckla MB Nat Genet; 1995 Nov; 11(3):331-4. PubMed ID: 7581460 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of the fragile X (FRAXA) syndrome with methylation-sensitive PCR. Weinhäusel A; Haas OA Hum Genet; 2001 Jun; 108(6):450-8. PubMed ID: 11499669 [TBL] [Abstract][Full Text] [Related]
34. Increase of FMRP expression, raised levels of FMR1 mRNA, and clonal selection in proliferating cells with unmethylated fragile X repeat expansions: a clue to the sex bias in the transmission of full mutations? Salat U; Bardoni B; Wöhrle D; Steinbach P J Med Genet; 2000 Nov; 37(11):842-50. PubMed ID: 11073538 [TBL] [Abstract][Full Text] [Related]
35. FMR1 gene deletion/reversion: a pitfall of fragile X carrier testing. Gasteiger M; Grasbon-Frodl E; Neitzel B; Kooy F; Holinski-Feder E Genet Test; 2003; 7(4):303-8. PubMed ID: 15000806 [TBL] [Abstract][Full Text] [Related]
37. [Experimental therapy: reactivation of the FMR1 gene involved in fragile X syndrome]. Chiurazzi P; Neri G Rev Neurol; 2001 Oct; 33 Suppl 1():S62-5. PubMed ID: 12447822 [TBL] [Abstract][Full Text] [Related]
38. Molecular-intelligence correlations in young fragile X males with a mild CGG repeat expansion in the FMR1 gene. Steyaert J; Borghgraef M; Legius E; Fryns JP Am J Med Genet; 1996 Aug; 64(2):274-7. PubMed ID: 8844064 [TBL] [Abstract][Full Text] [Related]
39. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Snow K; Doud LK; Hagerman R; Pergolizzi RG; Erster SH; Thibodeau SN Am J Hum Genet; 1993 Dec; 53(6):1217-28. PubMed ID: 7902673 [TBL] [Abstract][Full Text] [Related]
40. Instability of the CGG repeat and expression of the FMR1 protein in a male fragile X patient with a lung tumor. de Graaff E; Willemsen R; Zhong N; de Die-Smulders CE; Brown WT; Freling G; Oostra B Am J Hum Genet; 1995 Sep; 57(3):609-18. PubMed ID: 7668289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]